PathogenDx Awarded Honorable Mention in the Pandemic Response Category of Fast Company's 2022 World Changing Ideas Awards
The Sixth Annual Fast Company World Changing Ideas Awards Honor the Products, Concepts, Companies, Policies and Designs that Are Driving Change and Tackling Issues from Public Health, Climate Change to Inequality and More
Scottsdale, Arizona--(Newsfile Corp. - May 3, 2022) - PathogenDx ("PathogenDx" or "Company"), a U.S.-based biotechnology company setting the standard in molecular-based testing through the widespread adoption of its advanced microarray testing platform for the human diagnostics, food and agricultural industries, announced that it has been awarded an honorable mention in Fast Company's 2022 World Changing Ideas Awards in the "Pandemic Response" category for its introduction of a new, customized COVID-19 testing portal, which rapidly and affordably detects all SARS-CoV-2 variants while streamlining data reporting for public health agencies, professionals and epidemiologists. The winners of Fast Company's 2022 World Changing Ideas Awards were announced today [May 3, 2022], and honor clean technology, innovative corporate initiatives, brave new designs for cities and buildings and other creative works that are supporting the growth of positive social innovation, tackling social inequality, climate change and public health crises.
Leveraging its learnings from the agile development of COVID-19 diagnostics, the NIH-RADx program brings to life a new generation genotyping diagnostic with capability to deliver sequencing accuracy at high volume but a fraction of the cost. PathogenDx's Detectx-Cv has already detected all major variants, providing results in four hours after receiving a positive sample from any Covid-19 test, running up to 576 samples in a single shift for a fraction of the cost of NGS Sequencing.
"We are humbled to have the hard work of our talented team be recognized by Fast Company's 2022 World Changing Ideas Awards," said Milan Patel, co-founder and CEO of PathogenDx. "We are grateful to the NIH and the RADx program for their support in helping bring Detectx-Cv+ to market. The launch of our Detectx-Cv+ assay in genotyping mutations is just the tip of the iceberg in applying this breakthrough technology across other clinical diagnostics segments. Ultimately, as we introduce new products off this platform, the patients, providers and payers will win, with broader access and better health information, improved clinical utility and lower cost. The performance horsepower of our multiplex microarray has overcome the sensitivity limitations of qRT-PCR technologies with 'single gene mutational' accuracy similar to Next Generation Sequencing ('NGS') while delivering high volume throughput testing at one-tenth the cost. It is the right platform solution that is gravely needed in the diagnostics sector given what we have learned and experienced with variants sprouting off SARS-CoV-2, and the ever growing challenges we are facing not only on the infectious disease side with antibiotic resistance, but across other clinical diagnostics sectors."
"We are consistently inspired by the novelty and creativity that people are applying to solve some of our society's most pressing problems, from shelter to climate crisis. At Fast Company, we release this list to amplify companies doing vital, innovative work to address some of the big challenges facing the world today," says David Lidsky, interim editor-in-chief of Fast Company. "Our journalists have identified some of the most ingenious initiatives to launch since the start of 2021, which we hope will both have a meaningful impact and lead others to join in being part of the solution."
Now in its sixth year, the World Changing Ideas Awards showcase 39 winners, 350 finalists and more than 600 honorable mentions - with climate change, social justice and AI and data being among the most popular categories. A panel of eminent Fast Company editors and reporters selected winners and finalists from a pool of more than 2,997 entries in the fields of transportation, education, food, politics, technology, health, social justice and more. In addition, several new categories have been added this year, including climate, nature, water and workplace.
The 2022 awards feature entries from across the globe, from Switzerland to Hong Kong to Australia. Fast Company's Summer 2022 issue, which will hit the newsstands on Tuesday, May 10, 2022, will showcase some of the world's most innovative entrepreneurs and companies tackling the most important global challenges. The issues highlight, among others, probiotics for coral reefs, easy-to-assemble kit homes for refugees or disaster survivors, a 3D-printed vaccine patch, an electric truck, a system to heat homes from the waste heat of a name-brand factory and prosecutor-initiated resentencing for overly long prison sentences.
For more information, visit https://pathogendx.com/covid-19/.
About the World Changing Ideas Awards
World Changing Ideas is one of Fast Company's major annual awards programs and is focused on social good, seeking to elevate finished products and brave concepts that make the world better. A panel of judges from across sectors choose winners, finalists and honorable mentions based on feasibility and the potential for impact. With the goals of awarding ingenuity and fostering innovation, Fast Company draws attention to ideas with great potential and helps expand their reach to inspire more people to start working on solving problems that affect us all.
Headquartered in Scottsdale, Arizona, PathogenDx's mission is to become the new standard in DNA-based testing through widespread adoption of its advanced microarray testing platform for the human diagnostics, food and agricultural industries. PathogenDx's technology can rapidly identify and detect up to 50 pathogens all in a single test, in six hours providing triplicate data per analyte for certainty in results with a simple and easy process. The company's DNA-testing products - Detectx™, Quantx™ and Envirox™ are disrupting the century old practice of petri dish testing to identify, detect and quantify pathogens that threaten human health, our ecosystem and the environment. This technology will help growing businesses deliver safer products leading to healthier lives, while preventing billions of dollars in losses from infection and contamination. For more information on how you can utilize this simple, powerful and inexpensive DNA-based pathogen testing, visit www.pathogendx.com.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/122472